Related Experiment Video
Updated: Jul 18, 2026
05:52
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Neutropenia: state of the knowledge part II.
Anita Nirenberg1, Annette Parry Bush, Arlene Davis
1School of Nursing, Columbia University, New York, NY, USA. an207@columbia.edu
Oncology Nursing Forum
|December 7, 2006
Summary
Oncology nurses need evidence-based practices to manage chemotherapy-induced neutropenia (CIN) complications. While some interventions like hand washing are supported, many current practices lack empirical evidence for patient safety.
Area of Science:
- Oncology Nursing
- Hematology
- Evidence-Based Practice
Background:
- Chemotherapy-induced neutropenia (CIN) is a common and serious complication in cancer patients.
- Effective nursing interventions are crucial for predicting, preventing, and managing CIN complications.
- Current evidence for nursing interventions in CIN management requires synthesis and dissemination.
Purpose of the Study:
- To summarize available evidence for oncology nurses regarding CIN.
- To guide nurses in predicting and preventing CIN complications.
- To enhance patient education and understanding of neutropenia management.
Main Methods:
- Comprehensive review of primary literature, meta-analyses, and systematic reviews.
- Analysis of clinical practice guidelines.
- Inclusion of discussions from the State of the Knowledge on Neutropenia Symposium.
Main Results:
- Evidence for nursing interventions to prevent CIN complications is underdeveloped.
- Strong empirical support is lacking for interventions like dietary restrictions and isolation procedures.
- Preventive measures such as patient hand washing and skin care have a stronger evidence base.
Conclusions:
- While some nursing interventions to prevent infection in CIN patients have strong evidence, many current practices lack empirical support.
- Oncology nurses should review and revise care standards based on evidence.
- Further research and performance improvement projects are needed to enhance evidence-based care for patients with CIN.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...